Tag Archives: Lung cancer

Exosomes can confer drug resistance

exosomes

Exosomes derived from lung cancer cells confer cisplatin (DDP) resistance to other cancer cells. However, the underlying mechanism is still unknown. A549 resistance to DDP (A549/DDP) was established. Microarray was used to analyze microRNA (miRNA) expression profiles of A549 cells, ...

Read More »

Exosomes – a new horizon in lung cancer

exosomes

Lung cancer is one of the main cancer killers worldwide. Despite the increase of biological knowledge, the clinical outcome of patients diagnosed with advanced disease is still disappointing. Indeed, the survival rate falls dramatically from early- to advanced-stage cancer. Diagnostic ...

Read More »

Liquid Biopsy in Non-Small Cell Lung Cancer

exosomes

Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached its full potential, liquid biopsy-based ...

Read More »